GRAIL, Inc. (NL0)
XDUS
Closed
Oct 19, 2026
Day's Range
104.5552 wk Range
35.00Overview - NL0 - GRAIL, Inc.
Key Statistics
Valuation
Enterprise Value
840.09M
P/E (Trailing)
‪-10.49‬
PEG Ratio
‪0.53‬
Price / Sales (TTM)
‪31.51‬
Price / Book
‪2.37‬
EV / EBITDA
‪-2.48‬
Profitability
Gross Margin
‪-28.12%‬
Profit Margin
‪-236.94%‬
Operating Margin
‪-331.99%‬
Return on Assets
‪-12.03%‬
Return on Equity
‪-16.12%‬
Ownership
Shares Outstanding
44.66M
Float
34.32M
Held by Insiders
‪4.91%‬
Held by Institutions
‪86.28%‬
Price stats
Beta
‪2.83‬
50-Day Avg
‪79.24‬
200-Day Avg
‪63.15‬
Market Cap - NL0 - GRAIL, Inc.
Profile Summary - NL0 - GRAIL, Inc.
About
GRAIL, Inc. is a commercial-stage healthcare company focused on multi-cancer early detection testing and services. Its core offering is Galleri, a blood-based screening test designed to detect multiple cancer types before symptoms appear, supporting earlier clinical evaluation and diagnosis. The company uses…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
